Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Comment by peteswimon Jan 13, 2011 4:02pm

261 Views

Post# 17968273

RE: Wall @ 0,10

Here's how it looked at the close......lets see if the same games ensue in the morning......

# Orders	Shares	Bid	Ask	Shares	# Orders
2	49000	0.085	0.095	60000	2
5	168500	0.080	0.100	87000	4
6	442000	0.075	0.105	50000	1
10	348500	0.070	0.120	20000	1
7	289000	0.065	0.125	35000	2